NDC 83034-003

Ohtuvayre 3 mg per 2.5 mL suspension

On the label: Merck Sharp & Dohme LLC.

Portugal: 1United States: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Hovione Farmaciencia, S.a.Loures, PortugalMakes the active ingredient and tests it Problems found, fixed voluntarilyOct 24, 2024 · 10 inspections
The Ritedose CorporationColumbia, SC, United StatesMakes it, tests it, packages it and labels it Problems found, fixed voluntarilyFeb 28, 2025 · 12 inspections
Instituto de Soldadura E QualidadePorto Salvo, PortugalTests it Problems found, fixed voluntarilyMar 22, 2024 · 1 inspection
Quality Chemical LaboratoriesWilmington, NC, United StatesTests it Problems found, fixed voluntarilyNov 20, 2024 · 5 inspections
The Ritedose CorporationColumbia, SC, United StatesPackages it and labels it Problems found, fixed voluntarilyFeb 28, 2025 · 12 inspections

Product details

Generic drug
Ensifentrine: every company that makes it
Form
suspension, respiratory (inhalation)
Strength
3 mg per 2.5 mL
Approval
NDA NDA217389
On the market since
Jun 26, 2024
Package NDCs
83034-003-01 83034-003-05 83034-003-60 83034-003-65
Official label
DailyMed (National Library of Medicine), updated Oct 13, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?